These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 7234217)
21. Identification of differentially expressed genes in the high and low metastatic human ovarian cancer cell lines and analyses of their chromosomal localizations and functions. Xu SH; Mu HZ; Gu LH; Zhu CH; Liu XL Yi Chuan Xue Bao; 2006 Oct; 33(10):892-900. PubMed ID: 17046589 [TBL] [Abstract][Full Text] [Related]
22. Allele loss on chromosome arm 6q and fine mapping of the region at 6q27 in epithelial ovarian cancer. Cooke IE; Shelling AN; Le Meuth VG; Charnock ML; Ganesan TS Genes Chromosomes Cancer; 1996 Apr; 15(4):223-33. PubMed ID: 8703848 [TBL] [Abstract][Full Text] [Related]
23. Different mechanisms of mitotic instability in cancer cell lines. Klein A; Zang KD; Steudel WI; Urbschat S Int J Oncol; 2006 Dec; 29(6):1389-96. PubMed ID: 17088976 [TBL] [Abstract][Full Text] [Related]
24. [Establishment and biological characteristics of an immortalized human ovarian sarcomatoid carcinoma cell line BUPH:OVSC-2]. Feng J; Liu GZ; Fu TY; Ye X; Yao Y Ai Zheng; 2002 Jul; 21(7):731-4. PubMed ID: 12479096 [TBL] [Abstract][Full Text] [Related]
25. [Studies into dependence of sensitivity of cytostatics on overlap index of ovarian cancer in cell cultures (author's transl)]. Schindler C Zentralbl Gynakol; 1982; 104(3):156-9. PubMed ID: 7043954 [TBL] [Abstract][Full Text] [Related]
26. Cytogenetic instability in ovarian epithelial cells from women at risk of ovarian cancer. Pejovic T; Yates JE; Liu HY; Hays LE; Akkari Y; Torimaru Y; Keeble W; Rathbun RK; Rodgers WH; Bale AE; Ameziane N; Zwaan CM; Errami A; Thuillier P; Cappuccini F; Olson SB; Cain JM; Bagby GC Cancer Res; 2006 Sep; 66(18):9017-25. PubMed ID: 16982743 [TBL] [Abstract][Full Text] [Related]
27. Specific cytogenetic changes in ovarian cancer involving chromosomes 6 and 14. Wake N; Hreshchyshyn MM; Piver SM; Matsui S; Sandberg AA Cancer Res; 1980 Dec; 40(12):4512-8. PubMed ID: 7438085 [TBL] [Abstract][Full Text] [Related]
28. Telomere-mediated mitotic disturbances in immortalized ovarian epithelial cells reproduce chromosomal losses and breakpoints from ovarian carcinoma. Gisselsson D; Lv M; Tsao SW; Man C; Jin C; Höglund M; Kwong YL; Jin Y Genes Chromosomes Cancer; 2005 Jan; 42(1):22-33. PubMed ID: 15390185 [TBL] [Abstract][Full Text] [Related]
29. The human ovarian teratocarcinoma cell line PA-1 demonstrates a single translocation: analysis with fluorescence in situ hybridization, spectral karyotyping, and bacterial artificial chromosome microarray. Sarraf S; Tejada R; Abawi M; Oberst M; Dennis T; Simon KC; Blancato J Cancer Genet Cytogenet; 2005 Aug; 161(1):63-9. PubMed ID: 16080959 [TBL] [Abstract][Full Text] [Related]
30. Establishment of a highly metastatic human ovarian cancer cell line (HO-8910PM) and its characterization. Shenhua X; Lijuan Q; Hanzhou N; Xinghao N; Chihong Z; Gu Z; Weifang D; Yongliang G J Exp Clin Cancer Res; 1999 Jun; 18(2):233-9. PubMed ID: 10464713 [TBL] [Abstract][Full Text] [Related]
31. Karyotypic and phenotypic variations between cell lines established from a primary colorectal tumour and two corresponding metastases from one patient. Grégoire M; Blottière HM; Muleris M; Douillard JY; Meflah K Invasion Metastasis; 1993; 13(5):253-66. PubMed ID: 7960578 [TBL] [Abstract][Full Text] [Related]
32. Immunologic characterization of tumor markers in human ovarian cancer cell lines. Kutteh WH; Miller DS; Mathis JM J Soc Gynecol Investig; 1996; 3(4):216-22. PubMed ID: 8796833 [TBL] [Abstract][Full Text] [Related]
33. High definition cytogenetics and oligonucleotide aCGH analyses of cisplatin-resistant ovarian cancer cells. Prasad M; Bernardini M; Tsalenko A; Marrano P; Paderova J; Lee CH; Ben-Dor A; Barrett MT; Squire JA Genes Chromosomes Cancer; 2008 May; 47(5):427-36. PubMed ID: 18273836 [TBL] [Abstract][Full Text] [Related]
34. Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A. Yu D; Wolf JK; Scanlon M; Price JE; Hung MC Cancer Res; 1993 Feb; 53(4):891-8. PubMed ID: 8094034 [TBL] [Abstract][Full Text] [Related]
35. Global analysis of chromosome X gene expression in primary cultures of normal ovarian surface epithelial cells and epithelial ovarian cancer cell lines. Benoît MH; Hudson TJ; Maire G; Squire JA; Arcand SL; Provencher D; Mes-Masson AM; Tonin PN Int J Oncol; 2007 Jan; 30(1):5-17. PubMed ID: 17143508 [TBL] [Abstract][Full Text] [Related]
36. Establishment of a novel human dedifferentiated liposarcoma cell line, FU-DDLS-1: conventional and molecular cytogenetic characterization. Nishio J; Iwasaki H; Ishiguro M; Ohjimi Y; Fujita C; Ikegami H; Ariyoshi A; Naito M; Kaneko Y; Kikuchi M Int J Oncol; 2003 Mar; 22(3):535-42. PubMed ID: 12579306 [TBL] [Abstract][Full Text] [Related]
37. Molecular cytogenetic characterization of primary cultures and established cell lines from non-medullary thyroid tumors. Foukakis T; Thoppe SR; Lagercrantz S; Dwight T; Weng WH; Svensson A; Höög A; Zedenius J; Wallin G; Lui WO; Larsson C Int J Oncol; 2005 Jan; 26(1):141-9. PubMed ID: 15586234 [TBL] [Abstract][Full Text] [Related]
38. Recurrent cytogenetic aberrations and loss of constitutional heterozygosity in ovarian carcinomas. Kiechle-Schwarz M; Bauknecht T; Karck U; Kommoss F; du Bois A; Pfleiderer A Gynecol Oncol; 1994 Nov; 55(2):198-205. PubMed ID: 7959284 [TBL] [Abstract][Full Text] [Related]
39. Cytogenetic characterization of seven human cancer cell lines by combining G- and R-banding, M-FISH, CGH and chromosome- and locus-specific FISH. Cottier M; Tchirkov A; Perissel B; Giollant M; Campos L; Vago P Int J Mol Med; 2004 Oct; 14(4):483-95. PubMed ID: 15375617 [TBL] [Abstract][Full Text] [Related]
40. 20q gain associates with immortalization: 20q13.2 amplification correlates with genome instability in human papillomavirus 16 E7 transformed human uroepithelial cells. Savelieva E; Belair CD; Newton MA; DeVries S; Gray JW; Waldman F; Reznikoff CA Oncogene; 1997 Feb; 14(5):551-60. PubMed ID: 9053853 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]